Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Asenapine (Alias: Org 5222, ME2136, HSDB 8061)

Catalog No. T21360 Copy Product Info
Purity: 99.64%
🥰Excellent
Asenapine (Org 5222) is a 5-HT receptor, adrenergic receptor, dopamine receptor, and histamine receptor antagonist with antipsychotic effects that is used to treat schizophrenia and manic or mixed episodes associated with bipolar 1 disorder.721483-46-5

Asenapine

Copy Product Info
🥰Excellent
Catalog No. T21360
Alias Org 5222, ME2136, HSDB 8061

Asenapine (Org 5222) is a 5-HT receptor, adrenergic receptor, dopamine receptor, and histamine receptor antagonist with antipsychotic effects that is used to treat schizophrenia and manic or mixed episodes associated with bipolar 1 disorder.721483-46-5

Asenapine
Cas No. 65576-45-6
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$32In StockIn Stock
5 mg$72In StockIn Stock
10 mg$98In StockIn Stock
25 mg$168In StockIn Stock
50 mg$247In StockIn Stock
100 mg$365-In Stock
1 mL x 10 mM (in DMSO)$80In StockIn Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.64%
Appearance:Oil
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Asenapine (Org 5222) is a 5-HT receptor, adrenergic receptor, dopamine receptor, and histamine receptor antagonist with antipsychotic effects that is used to treat schizophrenia and manic or mixed episodes associated with bipolar 1 disorder.721483-46-5
Targets&IC50
α1-adrenoceptor:8.9 (pKi), α2C-adrenoceptor:8.9 (pKi), α2A-adrenoceptor:8.9 (pKi), D2 Receptor:8.9 (pKi), 5-HT6 receptor:9.6 (pKi), H1 Receptor:9.0 (pKi), 5-HT7 receptor:9.9 (pKi), H2 receptor:8.2 (pKi), D3 receptor:9.4 (pKi), 5-HT2A receptor:10.2 (pKi), 5-HT5 Receptor:8.8 (pKi), 5-HT2C receptor:10.5 (pKi), D4 Receptor:9.0 (pKi), 5-HT1A receptor:8.6 (pKi), D1 receptor:8.9 (pKi), α2B-adrenoceptor:9.5 (pKi), 5-HT2B receptor:9.8 (pKi), 5-HT1B receptor:8.4 (pKi)
In vitro
In comparison with the antipsychotics, asenapine showed high affinity and a different rank order of binding affinities (pKi) for serotonin receptors (5-HT1A [8.6], 5-HT1B [8.4], 5-HT2A [10.2], 5-HT2B [9.8], 5-HT2C [10.5], 5-HT5 [8.8], 5-HT6 [9.6] and 5-HT7 [9.9]), adrenoceptors (alpha1 [8.9], alpha2A [8.9], alpha2B [9.5] and alpha2C [8.9]), dopamine receptors (D1 [8.9], D2 [8.9], D3 [9.4] and D4 [9.0]) and histamine receptors (H1 [9.0] and H2 [8.2])[2].
In vivo
Asenapine (0.05-0.2 mg/kg, s.c.) induced a dose-dependent suppression of CAR (no escape failures recorded) and did not induce catalepsy. Additionally, it increased dopamine efflux in both the medial prefrontal cortex (mPFC) and the nucleus accumbens (NAc)[2].
SynonymsOrg 5222, ME2136, HSDB 8061
Chemical Properties
Molecular Weight285.77
FormulaC17H16ClNO
Cas No.65576-45-6
Smiles[H][C@@]12CN(C)C[C@@]1([H])c1cc(Cl)ccc1Oc1ccccc21
Relative Density.1.231
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: Insoluble
DMSO: 80 mg/mL (279.95 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (11.55 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4993 mL17.4966 mL34.9932 mL174.9659 mL
5 mM0.6999 mL3.4993 mL6.9986 mL34.9932 mL
10 mM0.3499 mL1.7497 mL3.4993 mL17.4966 mL
20 mM0.1750 mL0.8748 mL1.7497 mL8.7483 mL
50 mM0.0700 mL0.3499 mL0.6999 mL3.4993 mL
100 mM0.0350 mL0.1750 mL0.3499 mL1.7497 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Asenapine | purchase Asenapine | Asenapine cost | order Asenapine | Asenapine chemical structure | Asenapine in vivo | Asenapine in vitro | Asenapine formula | Asenapine molecular weight